NASDAQ: POM
Pomdoctor Ltd Earnings Dates, Reports, Calls

Pomdoctor earnings were -$31.3M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest POM earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, POM reported annual earnings of -$30.2M, with 53.8% growth.

POM earnings history

Current Revenue
$56.8M
Current Earnings
-$30.2M
Current Profit Margin
-53.2%

POM Return on Equity

Insufficient data to display

POM Return on Assets

Current Company
-276.5%
Current Industry
-48%
POM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when POM announces earnings.

POM Return on Capital Employed

Current Company
106.72%
Current Industry
-1,645.4%

POM vs Pharmaceutical Retailer Stocks

TickerEBITDAEarningsY/Y EarningsEPS
POM-$17.34M-$31.26MN/A-$0.54
SCNX-$39.45M-$41.85MN/A-$2.51
RDGT$15.26M$12.41MN/A$2.25
HKPD$431.41k-$701.88kN/A-$0.07
WGRX-$68.26M-$76.59MN/A-$45.00

Pomdoctor Earnings Reports & History FAQ

What were Pomdoctor's earnings last quarter?

Pomdoctor (NASDAQ: POM) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total POM earnings for the quarter were N/A. In the same quarter last year, Pomdoctor's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Pomdoctor stock.

Is Pomdoctor profitable or losing money?

As of the last Pomdoctor earnings report, Pomdoctor is currently losing money. Pomdoctor's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$18.60 million, a 263.61% increase year over year.

What was POM's earnings growth in the past year?

As of Pomdoctor's earnings date in Q2 2026, Pomdoctor's earnings has grown year over year. POM earnings in the past year totalled -$31.26 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.